Exchange: NASDAQ·Updated 07:57 PM EDT
ERNA logo

ERNA Ernexa Therapeutics Inc.

$4.17
$0.145
(3.61%)
Today
Closed $4.17
$0.015
(0.36%)
After Hours
Mkt Cap$6.8M
Vol19,816.00

About ERNA

Ernexa Therapeutics, Inc. engages in the research and development of cellular therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. Its pipeline includes ERNA-101 (Ovarian Cancer) and ERNA-201 (Rheumatoid Arthritis). The company was founded in 1984 and is headquartered in Cambridge, MA.
49

Neutral Sentiment

How do you feel about ERNA?

Advertisement|Remove ads.